Tumor sequencing and xenografts allow scientists to look across the genome at abnormalities that are associated with no response or poor response to chemotherapy.
Sequencing uncovers genetic makeup of aggressive tumor
Introduction to the IM Clinic
Konstantinos Lazaridis, M.D. Co-Director, Clinomics Program
The Center for Individualized Medicine discovers and integrates the latest in genomic, molecular and clinical sciences into personalized care for patients. Watch